Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07670754
NA

ORASIS in Breast Reconstruction

Sponsor: Duke University

View on ClinicalTrials.gov

Summary

The purpose of this study is to assess the use of ORASIS during microsurgical anastomosis formation in DIEP (Deep Inferior Epigastric Perforator) flap breast reconstruction and its potential effects on surgical precision, surgeon efficiency, and anastomosis outcomes. The investigators hypothesize that the use of ORASIS will decrease the amount of time needed to perform microsurgical anastomoses, reduce interruptions for irrigation and suction, and increase the quality of anastomoses in DIEP flap breast reconstruction.

Official title: ORASIS and Microsurgical Anastomosis Outcomes in DIEP Flap Breast Reconstruction: A Crossover Randomized Controlled Trial

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2026-12

Completion Date

2027-12

Last Updated

2026-06-26

Healthy Volunteers

No

Interventions

DEVICE

Use of ORASIS Device

The study intervention is the use of the ORASIS device during microsurgical anastomosis formation in DIEP flap breast reconstruction procedures. ORASIS is a dual irrigation and suction device that can be placed in the surgical field during the formation of microsurgical anastomoses. The device was previously registered with the FDA under registration number 878.4200; the device is currently not registered with the FDA as it is pending renewal. The device is manufactured by a partner company (Spectroplast/Ricoh UK) with demonstrated compliance to international quality standards. The manufacturer has successfully implemented the ISO 9001 Quality Management System across all operational areas following a comprehensive audit process, that supports compliance with FDA cGMP requirements (21 CFR Part 820) for Class I medical devices. Spectroplast/Ricoh UK is certified under FDA ISO 10993 standards for biological evaluation of medical devices.

Locations (2)

Duke University Medical Center

Durham, North Carolina, United States

Duke Raleigh Hospital

Raleigh, North Carolina, United States